HEADER SUGAR BINDING PROTEIN 03-FEB-23 8G21 TITLE REELIN C-TERMINAL REGION COMPND MOL_ID: 1; COMPND 2 MOLECULE: REELIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL RESIDUES 3429-3460; COMPND 5 EC: 3.4.21.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RELN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS ALZHEIMERS DISEASE, GAG INTERACTION, SUGAR BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.S.CHANDRAHAS,C.MARINO,J.F.ARBOLEDA-VELASQUEZ REVDAT 3 15-MAY-24 8G21 1 REMARK REVDAT 2 07-JUN-23 8G21 1 AUTHOR JRNL REVDAT 1 31-MAY-23 8G21 0 JRNL AUTH F.LOPERA,C.MARINO,A.S.CHANDRAHAS,M.O'HARE, JRNL AUTH 2 N.D.VILLALBA-MORENO,D.AGUILLON,A.BAENA,J.S.SANCHEZ, JRNL AUTH 3 C.VILA-CASTELAR,L.RAMIREZ GOMEZ,N.CHMIELEWSKA,G.M.OLIVEIRA, JRNL AUTH 4 J.L.LITTAU,K.HARTMANN,K.PARK,S.KRASEMANN,M.GLATZEL, JRNL AUTH 5 D.SCHOEMAKER,L.GONZALEZ-BUENDIA,S.DELGADO-TIRADO, JRNL AUTH 6 S.AREVALO-ALQUICHIRE,K.L.SAEZ-TORRES,D.AMARNANI,L.A.KIM, JRNL AUTH 7 R.C.MAZZARINO,H.GORDON,Y.BOCANEGRA,A.VILLEGAS,X.GAI, JRNL AUTH 8 M.BOOTWALLA,J.JI,L.SHEN,K.S.KOSIK,Y.SU,Y.CHEN,A.SCHULTZ, JRNL AUTH 9 R.A.SPERLING,K.JOHNSON,E.M.REIMAN,D.SEPULVEDA-FALLA, JRNL AUTH10 J.F.ARBOLEDA-VELASQUEZ,Y.T.QUIROZ JRNL TITL RESILIENCE TO AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE IN A JRNL TITL 2 REELIN-COLBOS HETEROZYGOUS MAN. JRNL REF NAT MED V. 29 1243 2023 JRNL REFN ISSN 1546-170X JRNL PMID 37188781 JRNL DOI 10.1038/S41591-023-02318-3 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2.1 REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 20 BEST STRUCTURES SUPERIMPOSED ON REMARK 3 BACKBONE ATOMS (N,CA,C,O) REMARK 4 REMARK 4 8G21 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000272047. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.15 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 3.3 MM [U-98% 15N] REELIN CTR, REMARK 210 50 % V/V THF (CF3-CD2-OH), 0.25 MM DSS (4,4-DIMETHYL-4- REMARK 210 SILAPENTANE-1-SULFONIC ACID), 50% H2O/50% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1H TOCSY; 1H NOESY; 2D 1H-15N; REMARK 210 2D 1H-13C REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DIRECT DRIVE REMARK 210 SPECTROMETER MANUFACTURER : AGILENT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 2.3.2, PSVS, CCPNMR REMARK 210 ANALYSIS 2.4.2, NMRPIPE, PYMOL REMARK 210 2.5.4, CNS 1.2.1 REMARK 210 METHOD USED : NA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 30 115.37 -162.03 REMARK 500 2 TYR A 31 134.86 70.57 REMARK 500 3 TYR A 31 138.43 69.89 REMARK 500 4 TYR A 31 151.44 73.63 REMARK 500 8 ARG A 30 39.77 -89.17 REMARK 500 9 TYR A 31 145.88 74.15 REMARK 500 12 ARG A 30 53.17 -90.35 REMARK 500 13 ARG A 30 80.41 54.41 REMARK 500 15 TYR A 31 132.27 70.53 REMARK 500 16 ARG A 30 81.23 57.27 REMARK 500 18 TYR A 31 134.88 77.98 REMARK 500 19 ARG A 30 -155.64 -117.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 31073 RELATED DB: BMRB REMARK 900 REELIN C-TERMINAL REGION DBREF 8G21 A 1 32 UNP P78509 RELN_HUMAN 3429 3460 SEQRES 1 A 32 SER THR ARG LYS GLN ASN TYR MET MET ASN PHE SER ARG SEQRES 2 A 32 GLN HIS GLY LEU ARG HIS PHE TYR ASN ARG ARG ARG ARG SEQRES 3 A 32 SER LEU ARG ARG TYR PRO HELIX 1 AA1 THR A 2 ARG A 30 1 29 CISPEP 1 TYR A 31 PRO A 32 1 -1.32 CISPEP 2 TYR A 31 PRO A 32 2 -0.67 CISPEP 3 TYR A 31 PRO A 32 3 -3.11 CISPEP 4 TYR A 31 PRO A 32 4 -2.60 CISPEP 5 TYR A 31 PRO A 32 5 -2.12 CISPEP 6 TYR A 31 PRO A 32 6 -2.30 CISPEP 7 TYR A 31 PRO A 32 7 -2.71 CISPEP 8 TYR A 31 PRO A 32 8 -10.35 CISPEP 9 TYR A 31 PRO A 32 9 -6.09 CISPEP 10 TYR A 31 PRO A 32 10 -1.72 CISPEP 11 TYR A 31 PRO A 32 11 -5.64 CISPEP 12 TYR A 31 PRO A 32 12 0.16 CISPEP 13 TYR A 31 PRO A 32 13 -2.55 CISPEP 14 TYR A 31 PRO A 32 14 -0.06 CISPEP 15 TYR A 31 PRO A 32 15 -1.04 CISPEP 16 TYR A 31 PRO A 32 16 -2.79 CISPEP 17 TYR A 31 PRO A 32 17 -0.73 CISPEP 18 TYR A 31 PRO A 32 18 -0.07 CISPEP 19 TYR A 31 PRO A 32 19 -4.74 CISPEP 20 TYR A 31 PRO A 32 20 -1.58 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1